NGM Biopharmaceuticals
NGM
$1.54
Share price
0.00%
Change (1 day)
-53.89%
Change (1 year)
Categories
Operating Margin for NGM Biopharmaceuticals (NGM)
Operating Margin as of June 2024 (TTM): -485.54%
According to NGM Biopharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -485.54%. At the end of 2021 the company had an Operating Margin of -154.97%.
Operating Margin history for NGM Biopharmaceuticals from 2018 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -154.97% | 30.4% |
| 2020 | -118.85% | 149.41% |
| 2019 | -47.65% | 1100.28% |
| 2018 | -3.97% | -82.42% |
| 2017 | -22.59% | 131.23% |
| 2016 | -9.77% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -92.51% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | 1,628.21% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.